MetaCap

Genprex (GNPX) vs 60 Degrees Pharmaceuticals (SXTP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

60 Degrees Pharmaceuticals is the larger company by market cap ($2.1 million vs $1.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GNPX-44.66%SXTP-57.44%
+8%-26%-61%
Oct 7, 20261 yearNov 20, 2026
GNPX-46.69%SXTP-51.50%
+3%-26%-54%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GNPX versus SXTP key metrics
MetricGNPXSXTP
Share price$1.45$0.4682
Market cap$1.94M$2.10M
1-day change-13.17%-6.36%
P/E ratio (TTM)0.01—
EPS (TTM)$98.47$-5.34
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$1.01M
Revenue growth (YoY)—+65.49%
Net income (latest FY)$-16.23M$-7.37M
Gross margin—22.26%
Operating margin—-771.64%
Net margin—-732.51%
52-week high$80.96$8.62
52-week low$1.45$0.46
Distance from 52-week high-98.21%-94.57%
Analyst consensus—none
Avg. price target upside—+690.26%
Average volume168.88K407.29K
Shares outstanding1.33M4.48M
Employees133
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Genprex

GNPX stock →

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.

Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees

About 60 Degrees Pharmaceuticals

SXTP stock →

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment.

Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees

GNPX vs SXTP FAQ

Which is bigger, Genprex or 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (SXTP) is larger, with a market capitalization of $2.10M compared with $1.94M for Genprex (GNPX).

Are Genprex and 60 Degrees Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons